Biotech Consulting: A Pitfalls Checklist for Grant-Funded Work

Federal and foundation grants typically come with their own rules for what costs can be charged to the grant, how indirect costs are calculated, and what documentation has to support every dollar billed. Private engagements have none of that structure and are governed only by the contract with the client. A controller who applies a single simplified cost allocation across both types of work risks either under-billing a grant for costs it could legitimately cover, or worse, billing a grant for costs that don't actually qualify, which can jeopardize the relationship with the funder on future awards.

Grant funds are often restricted to a specific project or purpose, and spending them on general overhead or a different engagement, even temporarily as a cash flow bridge, can create a compliance problem that is expensive to unwind. A controller who tracks restricted grant funds in a separate ledger, never commingled with the firm's general operating cash, avoids a mistake that is far more serious here than a typical bookkeeping error would be in most other industries on this list, and far more costly to repair once a funder has lost confidence in the firm's stewardship of its money.

Private engagements tied to regulatory or development milestones, a study completion, a filing submission, a specific deliverable, should generally have revenue recognized when the milestone is actually achieved, not when work merely begins toward it. Booking milestone revenue early, especially on a milestone that later slips or doesn't materialize, can force an uncomfortable revenue reversal later. A controller who ties revenue recognition strictly to achieved milestones, documented clearly, avoids that whiplash.

Work touching drug development, clinical trial design, or regulatory strategy can carry liability exposure well beyond what a typical consulting engagement would, and insurance needs should be evaluated against the actual scope and risk of the work the firm is taking on, not against a generic professional services policy. This is worth a direct conversation with an insurance broker who understands life sciences consulting specifically, not an assumption carried over from a different kind of advisory practice.

Once grant compliance, restricted fund segregation and milestone billing are handled correctly, a fractional CFO's real contribution is strategic: deciding how much of the firm's capacity should go toward grant-funded work, which tends to be lower margin but more stable, versus private engagements, which can be higher margin but less predictable, and modeling what happens to firm cash flow if a major grant renewal is delayed or denied. The national median salary for accountants and auditors is $83,680 a year, and a controller with grant accounting experience specifically is worth paying above that baseline given the compliance stakes involved¹.

Say a firm depends on one large federal grant for a third of its revenue, and that grant's renewal decision is expected six months from now with real uncertainty about the outcome. Waiting until the renewal decision arrives to think about the consequences leaves no time to adjust staffing or pursue replacement work if the answer is no. A fractional CFO building a funding transition plan well ahead of the decision, including what private engagement pipeline would need to look like to offset a denial, turns an existential risk into a manageable planning exercise instead of a crisis that arrives with no warning.

Grant auditors and program officers can request supporting documentation well after a project has closed out, sometimes years later, and a firm that hasn't kept clean, organized records tied to each cost category can find itself scrambling to reconstruct justification for spending that happened long ago. A controller who builds documentation discipline into the workflow from the start of each grant, rather than treating it as a task to catch up on before an audit, is protecting the firm's ability to win future awards from the same funder down the road, not just satisfying a compliance checkbox on the current one.

A controller can guard against these pitfalls with a handful of habits:

• Apply separate cost rules to grant work and private engagements, including what can be charged to the grant and how indirect costs are calculated.
• Track restricted grant funds in their own ledger, never commingled with general operating cash, even as a temporary cash flow bridge.
• Recognize revenue on milestone-based private engagements when the milestone is actually achieved, not when work toward it begins.
• Review liability insurance against the real scope and risk of the work, ideally with a broker who understands life sciences consulting.
• Keep clean records tied to each cost category so grant auditors and program officers can be satisfied years after a project closes.